Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

    NHLBI Catalyze funds early research to find and validate drug therapies for heart, lung, blood, and sleep disorders, preparing them for further development.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

    NHLBI Catalyze program supports early-stage research to identify and characterize small molecule, biologic, and combination product therapeutic candidates for heart, lung, blood, and sleep (HLBS) disorders.

    HHS-NIH11Due Feb 11, 2027$800,000

    Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

    NHLBI Catalyze program supports early-stage medical device prototype optimization and translational research for heart, lung, blood, and sleep (HLBS) diseases.

    HHS-NIH11Due Feb 11, 2027$600,000

    Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

    NHLBI Catalyze funds early-stage medical device prototypes, disease target ID, & assay development for heart, lung, blood, & sleep disorders, aiming to prep projects for further testing.

    HHS-NIH11Due Nov 23, 2026· 7d

    Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

    NHLBI Catalyze grants fund platform technologies to accelerate the development of diagnostics and therapeutics for heart, lung, blood, and sleep disorders.

    HHS-NIH11Due Feb 11, 2027$700,000

    Therapeutic Catalyst

    Therapeutic Catalyst supports academic researchers in early drug discovery, funding target identification, validation and early antibody or small molecule development to advance treatments for adult cancers.

    CRUKDue Feb 5, 2027$350,000